| PERIOD ENDING | 31-Dec-08 | 31-Dec-07 | 31-Dec-06 | | Total Revenue | 26,931,077 | 29,350,014 | 25,974,096 | | Cost of Revenue | 17,357,803 | 17,827,422 | 15,265,551 | | | Gross Profit | 9,573,274 | 11,522,592 | 10,708,546 | | | Operating Expenses | | Research Development | 4,328,978 | 4,508,005 | 4,079,258 | | Selling General and Administrative | 3,476,949 | 3,394,680 | 2,262,797 | | Non Recurring |
-
| 4,064 | (862,867) | | Others |
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
| | | | Operating Income or Loss | 1,767,348 | 3,615,844 | 5,229,357 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 829,472 | 56,737 | 216,082 | | Earnings Before Interest And Taxes | 2,540,619 | 4,802,943 | 5,445,439 | | Interest Expense | 320,188 |
-
| 261,373 | | Income Before Tax | 2,220,431 | 4,802,943 | 5,184,066 | | Income Tax Expense | 716,555 | 1,343,242 | 1,373,778 | | Minority Interest |
-
|
-
|
-
| | | | Net Income From Continuing Ops | 1,503,876 | 3,459,701 | 3,810,288 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | 1,503,876 | 3,459,701 | 3,810,288 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $1,503,876 | $3,459,701 | $3,810,288 |
|
0.22% Nasdaq 
0.03 (0.31%) 
Income Statement
